Notre actualité
It is a pleasure to announce that HCS Pharma has a new collaborative project dealing with Inflammasome et ion channels Team of OncoLille (PHYCELL Lab, INSERM U1003) in the frame of colon cancer, thanks to France Relance plan and Region Hauts-de-France. This project has started in October 2022 for 2 Read more…
We are glad starting a new Year! But nothing better than assessing what happened along the last one to glance back at the road traveled so far… and looking forward to what’s next!
During the Healthcare Expo organized that take place in Taïwan between the 30th of November and the 3rd of December, our partner Tokyo Future Style Taiwan had a booth and presented BIOMIMESYS® technology. Dr Dar-Bin Shieh stayed a lot of time with our partner to discuss with Joseph and his Read more…
One week later after our business trip in Asia, we are lucky to welcome Pr Dar Bin Shieh from National Cheng Kung University (Taiwan) in Lille on the 16th of November. In the morning, we have been invited in OncoLille, we have presented all our work in oncology field with Read more…
🇬🇧 HCS PHARMA will be in Paris for the 15th edition of inescapable COSMET’AGORA event the 10 and 11 january 2023 ! Join Océane GUYOT, project manager in dermocosmetology, and Rita HIEN, business developer junior, at the event. Do not hesitate to solicit us if you want to know more Read more…
In order to make known BIOMIMESYS technology, Grégory and Nathalie were in Asia in October during one month. The first step was in Japan. We have worked with our partners from AS ONE and JVC Kenwood. We had the opportunity to visit them in AS ONE office in order to Read more…
We are pleased to welcome Paul Couvreur as a commercial apprentice on board of HCS Pharma. Graduated in international trade and now in an international business Master, Paul decided to get on board of HCS Pharma company as work-study student. His promise? Bring a commercial support in the pharmacology service Read more…
We were glad to participate in FIE (Food Ingredients Europe) fair, which took place from the 6th to the 8th of December in Paris (as a new place for the fair France). Elodie attended it as a visitor, allowing us to meet again our usual partners and to meet future Read more…
The congress of European Society of Toxicology In Vitro (ESTIV) took place from 21st to 25th November 2022. This congress is focus on the alternative methods to animal testing, including both in silico and in vitro modeling. After a nice opening ceremony with a flamenco show, the scientific program begun Read more…
Last week, our project leader Océane GUYOT was in Lisbon to participate in Skin Ageing & Challenges. We had the opportunity to present a short oral entitled Cell Imaging For Dermocosmetic Claims Substantation Through In Vitro Assessment On Cellular Skin Models. This presentation focused on the interest of cell imaging Read more…
Industry and academia are increasingly complexifying their in vitro models, not only 3D models but also organs-on-chip (OoC) in their studies. Such systems are needed for putting different tissues into contact, or to take into account flux-related aspects. BIOMIMESYS® being an ideal hydroscaffold™ for 3D cell culture, this webinar aims Read more…
Next week we will have the pleasure to attend FOOD INGREDIENTS EUROPE & HEALTH INGREDIENTS EUROPE (FIE/HIE), which will take place in Paris, Porte de Versailles. Food ingredients Europe has been uniting the world’s leading food & beverage suppliers, buyers, R&D experts and production specialists for over 35 years. Originally Read more…
BIOMIMESYS® permet de cultiver des cellules en 3D dans des conditions identiques à celle d’un organe humain et en utilisant exclusivement des composés physiologiques. Nous sommes non seulement capables de proposer un environnement dont la composition est celle du tissu désiré, mais qui en plus a les mêmes propriétés mécaniques de rigidité et de porosité.
The first edition of OncoLille Days congress took place from November 2th to 4th, 2022 in Lille. All 3 days were very rich in interesting presentations about interdisciplinary research in oncology, including biology, mathematics, human sciences, etc. Our project leader Véronique De Conto was pleased to present her poster about Read more…
Our Project Leader in in vitro pharmacology Méryl Roudaut will present his presentation entitled “A single procedure to generate functional hiPSCs-derived liver organoids – Towards an innovative tools suitable for drug screening” during the session: Early Stage Researcher Session I (Tuesday, November 22nd, 2022). Abstract #165: We previously showed that Read more…
We are pleased to participate to the 21st International Congress of the European Society of Toxicology In Vitro (ESTIV 2022), which will take place in Barcelona-Sitges, Spain, from 21st to 25th November 2022. Our project Leader in in vitro pharmacology Véronique De Conto will present her poster entitled “In vitro microenvironment modifies the neurotoxic Read more…
We will have the pleasure to participate in the 13th Annual Meeting on Skin Ageing & Challenges which will be organized on November 17-18, 2022 at Altis Grand Hotel, Lisbon, Portugal and Online. This congress focus to provide answers and to give a future vision and trends on how can Read more…
Nous avons eu le plaisir d’être invités par notre distributeur Dutscher, et en particulier par Romain Guegan, à présenter lors de la journée Necker-Imagine organisée à l’INEM (Institut Necker Enfants Malades) le 3 novembre dernier. Elodie a eu l’occasion de présenter aux chercheurs présents notre technologie BIOMIMESYS® pour une culture Read more…
We are pleased to participate in the first OncoLille Days congress from November 2th to 4th, 2022. Inaugurated on October 12th, 2022, OncoLille Institute aims at developing an interdisciplinary research in oncology, including biology, physics, microtechnologies, chemistry, mathematics, bioinformatics, statisitcs, health technologies and social and human sciences. HCS Pharma collaborates Read more…
In October the expansion works started in HCS Pharma. The objective is to double the lab and office surface in the same building as our current premises, in the aim to expand BIOMIMESYS® production line to meet the growing demand while guaranteeing the quality of the products. These works will Read more…
Our project leader Méryl and our CBO Mathieu are currently attending CellME (Cell Manufacturing & Engineering) Forum taking place these days in Berlin, Germany. Méryl had the chance to present his work and the advantages of BIOMIMESYS® for organoid culture earlier today: Please feel free to discuss with them on Read more…
We are glad to announce the arrival of Gaspard in our team! Gaspard Delpouve obtained his Diploma of Advanced Technician in Biotechnologies in Lille in 2018, and in 2019 he passed a Bachelor’s degree in health biotechnologies at the University of Nantes. During his studies he completed several internships in Read more…
This is the end of the 6-month internship of Natacha in HCS Pharma, about the microenvironment modifications in Parkinson’s disease. Indeed, in vivo studies in the literature showed that the neuronal death in Parkinson’s disease involved Extracellular Matrix (ECM) modifications, including an increase in some components like collagen and a Read more…